Abstract:While most individuals suffer progressive disease following HIV infection, a small fraction spontaneously controls the infection. Although CD8 T-cells have been implicated in this natural control, their mechanistic roles are yet to be established. Here, we combined mathematical modeling and analysis of previously published data from 16 SIV-infected macaques, of which 12 were natural controllers, to elucidate the role of CD8 T-cells in natural control. For each macaque, we considered, in addition to the canonical in vivo plasma viral load and SIV DNA data, longitudinal ex vivo measurements of the virus suppressive capacity of CD8 T-cells. Available mathematical models do not allow analysis of such combined in vivo - ex vivo datasets. We explicitly modeled the ex vivo assay, derived analytical approximations that link the ex vivo measurements with the in vivo effector function of CD8-T cells, and integrated them with an in vivo model of virus dynamics, thus developing a new learning framework that enabled the analysis. Our model fit the data well and estimated the recruitment rate and/or maximal killing rate of CD8 T-cells to be up to 2-fold higher in controllers than non-controllers (p = 0.013). Importantly, the cumulative suppressive capacity of CD8 T-cells over the first 4–6 weeks of infection was associated with virus control (Spearman's ρ = -0.51; p = 0.05). Thus, our analysis identified the early cumulative suppressive capacity of CD8 T-cells as a predictor of natural control. Furthermore, simulating a large virtual population, our model quantified the minimum capacity of this early CD8 T-cell response necessary for long-term control. Our study presents new, quantitative insights into the role of CD8 T-cells in the natural control of HIV infection and has implications for remission strategies. HIV infection results in progressive disease culminating in AIDS in most individuals if left untreated. A rare set of individuals, called natural controllers, however, can control the virus without treatment. Understanding what underlies such control may help devise strategies to elicit it in non-controllers. A challenge has been the limited understanding of the mechanistic role of CD8 T-cells. Here, using new mathematical modeling which enabled simultaneous analysis of in vivo and ex vivo longitudinal data from macaques infected with SIV, we identified the cumulative infection suppressive capacity of CD8 T-cells early in infection (4–6 weeks) as a measurable correlate of control in the chronic phase of the infection. This cumulative suppressive capacity was significantly higher in controllers than non-controllers, attributed by our model to superior CD8 T-cell recruitment rate and/or maximal killing rate in the controllers. Our study quantifies the role of CD8 T-cells in the natural control of SIV and has implications for interventions targeting long-term HIV remission.

HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression

Identification of antibody targets associated with lower HIV viral load and viremic control

Heterogeneous Neutralizing Antibody and Anti Body-Dependent Cell Cytotoxicity Responses in Hiv-1 Elite Controllers

Transcriptional Profiling of CD4 T Cells Identifies Distinct Subgroups of HIV-1 Elite Controllers

T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable.

Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell–Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification

HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA

Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune control.

Distinct viral reservoirs in individuals with spontaneous control of HIV-1

Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts

Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers

Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data

Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.

Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers

Public T cell clonotypes are selected in HLA-B∗57:01+/HIV+ patients independently of the viral load

Glycoproteomic Study Reveals Altered Plasma Proteins Associated with HIV Elite Suppressors

The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

HIV-1 controllers possess a unique CD8+ T-cell activation phenotype and loss of control is associated with increased expression of exhaustion markers

Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers.

A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo

Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry